PUBLISHER: The Business Research Company | PRODUCT CODE: 1666390
PUBLISHER: The Business Research Company | PRODUCT CODE: 1666390
Anti-Aging Drugs Global Market Report 2025
Anti-aging drugs are a category of medications or supplements designed to decelerate or potentially reverse the aging process, addressing the underlying causes of aging and aiming to alleviate age-related illnesses.
The primary types of anti-aging drugs include serums, creams, gels, and other formulations. Serums are clear, yellowish liquids that remain after blood clotting and removal of blood cells. These drugs fall into various classes, including hormonal therapy, antioxidants, enzymes, stem cells, and others, available in forms such as injectables, oral medications, and topical applications. Various ingredients such as retinoid, hyaluronic acid, alpha hydroxy acid, among others, are applied to the skin and hair, targeting skeletal and muscle health, age-related disorders, and other aspects of the aging process.
The anti-aging drugs market research report is one of a series of new reports from The Business Research Company that provides anti-aging drugs market statistics, including anti-aging drugs industry global market size, regional shares, competitors with a anti-aging drugs market share, detailed anti-aging drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-aging drugs industry. This anti-aging drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anti-aging drugs market size has grown strongly in recent years. It will grow from$57.18 billion in 2024 to $61.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the rise in chronic diseases associated with aging, increasing awareness of aging-related health issues, regulatory support for aging research, and consumer focus on wellness and longevity
The anti-aging drugs market size is expected to see strong growth in the next few years. It will grow to $84.86 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of senolytic drugs, collaborations and partnerships in research, regulatory pathways for aging therapeutics, increased consumer adoption of anti-aging interventions. Major trends in the forecast period include targeted therapies and personalized medicine, senolytic drugs for cellular senescence, gene therapy and Crispr technologies, focus on mitochondrial health, microbiome modulation for longevity.
The growth of the anti-aging drugs market is anticipated to be fueled by the increasing aging population. This demographic shift highlights a rising proportion of individuals aged 60 years or older compared to other age cohorts within societies. This shift is a consequence of advancements in healthcare, resulting in extended lifespans, declining fertility rates, and transformations in social and economic structures. Anti-aging medications are aimed at extending the healthy lifespan of individuals who display youthful characteristics. For instance, according to the World Health Organization in October 2022, projections indicate that by 2030, one in every six individuals globally will be over 60 years old, marking an increase from 1 billion to 1.4 billion elderly individuals by 2020. Additionally, as per the Eurostat database, individuals aged 65 and above constituted 21.1% of the population, witnessing a 0.3% rise from the previous year and a 3.1% increase from a decade earlier. Hence, the surge in the aging population significantly propels the growth of the anti-aging drugs market.
The expansion of the anti-aging drugs market is expected to be driven by an increase in people's disposable income. This rise in disposable income typically correlates with economic improvements, leading to elevated wages, salaries, and heightened healthcare expenditures. Disposable income plays a pivotal role in influencing the usage of anti-aging drugs, as individuals with higher income levels often possess better accessibility and affordability for these treatments. This accessibility contributes to increased utilization, aiming to preserve a youthful appearance and tackle age-related concerns. For instance, data from the Bureau of Economic Analysis in August 2023 revealed a $7.3 billion rise (less than 0.1%) in disposable personal income and a $144.6 billion increase (0.8%) in personal consumption expenditures (PCE). Thus, the upsurge in people's disposable income significantly drives the growth of the anti-aging drugs market.
Embracing product innovation stands as a significant trend gaining traction within the anti-aging drugs market. Companies within this sector are actively integrating innovative products to fortify their market presence. For example, in April 2023, SkinCeuticals, a US-based leader in advanced skincare, unveiled the corrective cream A.G.E Interrupter Advanced. This product amplifies collagen matrix integrity, featuring a formulation infused with wild fruit flavonoids, glycyrrhetinic acid, and concentrated proxy lane (20% more than the original A.G.E Interrupter). A.G.E. Interrupter Advanced sets itself apart from standard anti-aging products by addressing all stages of the glycation process, rectifying existing signs of aging, and safeguarding against new and recurring damage induced by A.G.E. formation.
Leading companies in the anti-aging drug market are channeling efforts towards the development of cutting-edge skincare solutions aimed at combatting age-related conditions, promoting longevity, and enhancing overall health and well-being. Advanced skincare solutions for anti-aging encompass a spectrum of innovative products and treatments meticulously designed to target and diminish aging signs. These solutions elevate skin health and appearance through the utilization of state-of-the-art technologies and formulations. For instance, in August 2022, NutriGlow Cosmetics Pvt. Ltd., an India-based beauty product provider, introduced a limited-edition line of anti-aging skincare products on their platform. This range includes items such as NutriGlow Advanced Organics Anti Pigmentation Serum, Anti Pigmentation Night Cream, Age Repair Tightening Serum, Age Repair Tightening Day Cream, Vitamin C Skin Lightening Serum, and Vitamin C Skin Lightening Night Cream. These dermatologically-tested anti-aging products are infused with Vitamin C and Hyaluronic Acid, addressing various skin concerns such as dark spots, fine lines, hyperpigmentation, discoloration, and uneven skin tone for consumers.
In August 2024, L'Oreal, a U.S.-based manufacturer of beauty and hair products, acquired Galderma S.A. for an undisclosed amount. This acquisition strengthens L'Oreal's presence in the rapidly expanding injectables segment by leveraging Galderma's expertise in dermatology and aesthetics. This strategic move enables L'Oreal to diversify its product offerings and capitalize on the growing consumer demand for non-invasive beauty treatments. Galderma S.A. is a U.S.-based pharmaceutical company focused on dermatological treatments and skin care products.
Major companies operating in the anti-aging drugs market include L'Oreal S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sanofi S.A., Elysium Health Inc., Estee Lauder Companies Inc., AbbVie Inc., La Roche-Posay, Nu Skin Enterprises Inc., Dermafix Biotech Private Limited, The Procter & Gamble Company, Johnson & Johnson Services Inc., Sun Pharmaceutical Industries Ltd., BioTime Inc., PT. Daewoong Pharmaceutical Co. Ltd., Allergan plc, MMJ PhytoTech Limited, Revitacare, SciVision Biotech, Canbex Therapeutics Ltd., Lumenis Ltd., Cynosure Inc., Age Sciences Inc., ALMA LASERS Ltd., Bausch Health Companies Inc., Hansen Supplements, Ponce De Leon Health Inc. , Youth & Earth, Vitality Pro
North America was the largest region in the anti-aging drugs market in 2024. The regions covered in the anti-aging drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the anti-aging drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The anti-aging drugs market consists of sales of dermal fillers, botulinum toxin, anti-wrinkle products, and anti-stretch mark products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anti-Aging Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anti-aging drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anti-aging drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-aging drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Serums; Creams; Gels; Other Products
- 2) By Drug Class: Hormonal Therapy; Antioxidants; Enzymes; Stem Cells
- 3) By Type: Injectable; Oral; Topical
- 4) By Ingredient: Retinoid; Hyaluronic Acid; Alpha Hydroxy Acid; Other Ingredients
- 5) By Drug Application: Skin And Hair; Skeletal And Muscles; Age Related Disorders; Other Applications
- Subsegments:
- 1) By Serums: Anti-Aging Vitamin C Serums; Retinol Serums; Peptide Serums
- 2) By Creams: Moisturizing Anti-Aging Creams; Night Creams; Eye Creams
- 3) By Gels: Hydrating Anti-Aging Gels; Firming Gels; Exfoliating Gels
- 4) By Other Products: Masks; Supplements; Treatments
- Companies Mentioned: L'Oreal S.A.; Galderma S.A.; Merz Pharma GmbH & Co. KGaA; Sanofi S.A.; Elysium Health Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Anti-Aging Drugs Market Characteristics
3. Anti-Aging Drugs Market Trends And Strategies
4. Anti-Aging Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Anti-Aging Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Anti-Aging Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Anti-Aging Drugs Market Growth Rate Analysis
- 5.4. Global Anti-Aging Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Anti-Aging Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Anti-Aging Drugs Total Addressable Market (TAM)
6. Anti-Aging Drugs Market Segmentation
- 6.1. Global Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Serums
- Creams
- Gels
- Other Products
- 6.2. Global Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormonal Therapy
- Antioxidants
- Enzymes
- Stem Cells
- 6.3. Global Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable
- Oral
- Topical
- 6.4. Global Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Retinoid
- Hyaluronic Acid
- Alpha Hydroxy Acid
- Other Ingredients
- 6.5. Global Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Skin And Hair
- Skeletal And Muscles
- Age Related Disorders
- Other Applications
- 6.6. Global Anti-Aging Drugs Market, Sub-Segmentation Of Serums, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anti-Aging Vitamin C Serums
- Retinol Serums
- Peptide Serums
- 6.7. Global Anti-Aging Drugs Market, Sub-Segmentation Of Creams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Moisturizing Anti-Aging Creams
- Night Creams
- Eye Creams
- 6.8. Global Anti-Aging Drugs Market, Sub-Segmentation Of Gels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hydrating Anti-Aging Gels
- Firming Gels
- Exfoliating Gels
- 6.9. Global Anti-Aging Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Masks
- Supplements
- Treatments
7. Anti-Aging Drugs Market Regional And Country Analysis
- 7.1. Global Anti-Aging Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Anti-Aging Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Anti-Aging Drugs Market
- 8.1. Asia-Pacific Anti-Aging Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Anti-Aging Drugs Market
- 9.1. China Anti-Aging Drugs Market Overview
- 9.2. China Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Anti-Aging Drugs Market
- 10.1. India Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Anti-Aging Drugs Market
- 11.1. Japan Anti-Aging Drugs Market Overview
- 11.2. Japan Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Anti-Aging Drugs Market
- 12.1. Australia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Anti-Aging Drugs Market
- 13.1. Indonesia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Anti-Aging Drugs Market
- 14.1. South Korea Anti-Aging Drugs Market Overview
- 14.2. South Korea Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Anti-Aging Drugs Market
- 15.1. Western Europe Anti-Aging Drugs Market Overview
- 15.2. Western Europe Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Anti-Aging Drugs Market
- 16.1. UK Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Anti-Aging Drugs Market
- 17.1. Germany Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Anti-Aging Drugs Market
- 18.1. France Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Anti-Aging Drugs Market
- 19.1. Italy Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Anti-Aging Drugs Market
- 20.1. Spain Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anti-Aging Drugs Market
- 21.1. Eastern Europe Anti-Aging Drugs Market Overview
- 21.2. Eastern Europe Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Anti-Aging Drugs Market
- 22.1. Russia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Anti-Aging Drugs Market
- 23.1. North America Anti-Aging Drugs Market Overview
- 23.2. North America Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Anti-Aging Drugs Market
- 24.1. USA Anti-Aging Drugs Market Overview
- 24.2. USA Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Anti-Aging Drugs Market
- 25.1. Canada Anti-Aging Drugs Market Overview
- 25.2. Canada Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Anti-Aging Drugs Market
- 26.1. South America Anti-Aging Drugs Market Overview
- 26.2. South America Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Anti-Aging Drugs Market
- 27.1. Brazil Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Anti-Aging Drugs Market
- 28.1. Middle East Anti-Aging Drugs Market Overview
- 28.2. Middle East Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Anti-Aging Drugs Market
- 29.1. Africa Anti-Aging Drugs Market Overview
- 29.2. Africa Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Anti-Aging Drugs Market Competitive Landscape And Company Profiles
- 30.1. Anti-Aging Drugs Market Competitive Landscape
- 30.2. Anti-Aging Drugs Market Company Profiles
- 30.2.1. L'Oreal S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Elysium Health Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Anti-Aging Drugs Market Other Major And Innovative Companies
- 31.1. Estee Lauder Companies Inc.
- 31.2. AbbVie Inc.
- 31.3. La Roche-Posay
- 31.4. Nu Skin Enterprises Inc.
- 31.5. Dermafix Biotech Private Limited
- 31.6. The Procter & Gamble Company
- 31.7. Johnson & Johnson Services Inc.
- 31.8. Sun Pharmaceutical Industries Ltd.
- 31.9. BioTime Inc.
- 31.10. PT. Daewoong Pharmaceutical Co. Ltd.
- 31.11. Allergan plc
- 31.12. MMJ PhytoTech Limited
- 31.13. Revitacare
- 31.14. SciVision Biotech
- 31.15. Canbex Therapeutics Ltd.
32. Global Anti-Aging Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Anti-Aging Drugs Market
34. Recent Developments In The Anti-Aging Drugs Market
35. Anti-Aging Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Anti-Aging Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Anti-Aging Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Anti-Aging Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
